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Abstract 
The high volume of research focusing on extracting patient’s information from electronic health records (EHR) has led to an increase 
in the demand for annotated corpora, which are a very valuable resource for both the development and evaluation of natural lan-
guage processing (NLP) algorithms. The absence of a multi-purpose clinical corpus outside the scope of the English language, espe-
cially in Brazilian Portuguese, is glaring and severely impacts scientific progress in the biomedical NLP field. In this study, we devel-
oped a semantically annotated corpus using clinical texts from multiple medical specialties, document types, and institutions. We pre-
sent the following: (1) a survey listing common aspects and lessons learned from previous research, (2) a fine-grained annotation 
schema which could be replicated and guide other annotation initiatives, (3) a web-based annotation tool focusing on an annotation 
suggestion feature, and (4) both intrinsic and extrinsic evaluation of the annotations. The result of this work is the SemClinBr, a cor-
pus that has 1,000 clinical notes, labeled with 65,117 entities and 11,263 relations, and can support a variety of clinical NLP tasks 
and boost the EHR’s secondary use for the Portuguese language. 
 
Keywords:  
Natural Language Processing; Semantic annotation; Clinical narratives; Corpora; Gold standard. 
Graphical abstract 
 
 
Highlights 
• A survey described the essential aspects and lessons learned regarding biomedical semantic annotation. 
• A fine-grained and replicable annotation schema was defined. 
• An optimized web-based annotation tool supported the annotation process. 
• The SemClinBr corpus consists of 1,000 semantically annotated clinical notes from multiple institutions and medical special-
ties.  
• The intrinsic and extrinsic evaluation of the corpus corroborate its application in different clinical NLP tasks. 
 
1. Introduction 
In the past two decades, Natural Language Processing (NLP) researchers developed a large amount of work focused on extracting and 
identifying information among unstructured data (i.e., clinical narratives) stored in the Electronic Health Records (EHR) [1], in what 
they call the “secondary use of EHR” [2]. Consequently, the scientific community has an increasing demand for corpora with high-
quality annotations in order to develop and validate their methods [3]. Semantically annotated corpora can be very useful for both the 
development and evaluation of NLP and Machine Learning (ML) algorithms aiming to mine information from EHR [4]. When it 
comes to the clinical domain, this could be a major issue owing to privacy restrictions applied to EHR data: personal health infor-
mation (PHI) available should not be openly shared for research. Therefore, it is mandatory that we de-identify (anonymize) patient’s 
personal data before we use it, as determined by the Health Insurance Portability and Accountability Act (HIPAA)1.  
     Moreover, it is difficult to find a unique corpus that can be potentially applied in several clinical NLP tasks. Such a corpus would 
be an annotated collection with broad scope and in-depth characteristics, and would, at the same time, present entities with high gran-
ularity and comprehensive documents from the point of view of clinical specialties, types, and institutional origin. Working with a 
language outside the English scope could be another barrier, as most of the annotation work is in English, including the studies devel-
oped for shared-tasks and challenges (e.g., [5–12]). Very few initiatives have shared clinical reference corpora in other languages 
(e.g., [4,13]), and to the best of our knowledge, none of them are in Brazilian Portuguese (pt-br).  
     Aiming to structure a background to support the biomedical NLP field for pt-br language and address the gaps of broad scope/in-
depth clinical corpora outside the English scope, we developed a semantically annotated corpus to assist clinical NLP tasks, both in its 
evaluation and in its development. We used real clinical texts from multiple institutions, medical specialties, and document types. We 
defined an annotation schema with fine-granularity entities, described an annotation guidelines document to guide the annotators dur-
ing the process, and developed a new annotation tool with features that enabled faster and more reliable work. As our main contribu-
tions, we highlight (1) the SemClinBR, the first semantically annotated clinical corpus in pt-br; (2) our clinical corpora survey, which 
lists common steps and lessons learned in corpus development; (3) a replicable annotation schema; and (4) a web-based annotation 
tool with an annotation assistant incorporated. 
2. Related work 
The use of statistical NLP and ML allowed researchers to automatically retrieve information from biomedical texts and increased the 
need for gold standard (or ground-truth) corpora to support supervised strategies. Owing to the cost and issues related to annotation 
projects [14], it is important that the scientific community share its efforts to boost the use of biomedical data and enable researchers 
to exploit a common evaluation and development environment, which could make a comparison of different methods easier. 
     The prevalence of biomedical literature corpora over clinical corpora is evident in recent studies [5,14,15]. While the first (normal-
ly) deals with open scientific information (e.g., scientific papers, gene data), the second one utilizes EHR personal data, which re-
quire, among other things, an anonymization process and ethical committee approval so that the information can be used and releases 
to the research community. Nevertheless, various clinical semantic annotation initiatives have been developed and shared over the last 
10 years; we provide an overview of some of these studies in this section and try to characterize them by listing some of their com-
mon features.  
     The shared-tasks and research challenges are a well-known source of clinical annotated data, as they focus on the development of a 
specific trending clinical NLP task and provide a common evaluation background for the scientific community. The i2b2 challenges 
covered important clinical NLP tasks over almost a decade, including clinical data de-identification [16,17], patient smoking status 
 
1 https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html 
detection [18], obesity and co-morbidities recognition [19], medication extraction [20], concepts/assertions/relation extraction [7], co-
reference resolution [21], temporal relation extraction [22], and heart disease risk factors identification [23]. Some of the corpora an-
notations are described in their own papers [12,24–26] and available to the research community on i2b2 webpage2. Another important 
initiative is the SemEval evaluation series, which focuses on general semantic analysis systems, not only in the biomedical/clinical 
domain. However, they already shared corpora for specific clinical tasks, such as the “Analysis of Clinical Text” task on SemEval-
2014 [10] and SemEval-2015 [11], and the “Clinical TempEval” task on SemEval-2016 [27] and SemEval-2017 [28]. The 
ShARe/CLEF eHealth labs3 shared a set of annotated clinical notes for two shared-tasks editions [8,29] and for three different NLP 
tasks, namely (1) named entity recognition (NER) and normalization of disorders, (2) normalization of acronyms and abbreviations, 
and (3) patient information retrieval. 
     To provide a development and evaluation environment for clinical information extraction systems, the CLinical E-Science Frame-
work (CLEF) project built a semantically annotated corpus of clinical texts [5]. The project labeled entities, relations, modifiers, co-
reference, and temporal information within the text using a CLEF project tagset. Although its large size (20,234 clinical documents), 
the corpus focused on patients with neoplasms only. In a recent study, Patel et al., (2018)[30] built a large clinical entity corpus, with 
5,160 clinical documents from 40 different medical domains. They annotated a set of 11 semantic groups, which they mapped to the 
corresponding UMLS semantic types. 
     The THYME4 (Temporal Histories of Your Medical Events) corpus [31] is another example of a gold standard produced by anno-
tating clinical notes. The annotation process focused on event and relation annotation, especially with regard to temporal information. 
Finally, the MiPACQ corpus [32] features syntactic and semantic annotation of clinical narratives (127,606 tokens precisely). The 
semantic labeling followed the UMLS hierarchy of semantic groups [33] to avoid semantic type ambiguity. 
     What we have seen so far is a predominance of corpora built for the English language. We did not find any study focusing on clin-
ical semantic annotation for pt-br. However, there is a non-shared corpus in European Portuguese, named the MedAlert Discharge 
Letters Representation Model (MDLRM) and developed by Ferreira et al. (2010)[34]. They annotated a set of entities (i.e., Condition, 
Anatomical Site, Evolution, Examination, Finding, Location, Therapeutic, DateTime, and Value) in 90 discharge summaries from a 
hospital in Portugal aiming to evaluate a NER task. 
     Furthermore, there are some efforts dedicated to other languages, and we mention some of them below. For Spanish, experts anno-
tated the IxaMed-GS corpus [13] with entities and relations associated with diseases and drugs, using an adaptation of the SNOMED-
CT tagset. A notable 3-year-long work is the Medical Entity and Relation LIMSI annOtated Text corpus (MERLOT), which produced 
a corpus of 500 annotated clinical documents for the French language using an entity annotation scheme5 partially derived from the 
UMLS Semantic Groups [4]. 
     A recent study focused on German nephrology reports to build a fine-grained annotated corpus, following a concept type organiza-
tion similar to the UMLS semantic types/groups. The corpus consists of 118 discharge summaries and 1,607 short evolution notes 
[35]. Moreover, for the Swedish language, Skeppstedt et al. (2014)[36] annotated a set of highly relevant entities for building a patient 
overview (Disorder, Finding, Pharmaceutical Drug, and Body Structure) to train a NER algorithm previously applied to English clini-
cal texts. Their corpus has 45,482 tokens in the training set and 25,370 tokens in the evaluation set. 
     To realize cohesive, reliable, unbiased, and fast annotations, most studies share the following common steps:  
• double annotation → to reduce bias and improve reliability 
• guidelines/scheme definition → to improve reliability and support annotators  
• annotation agreement measures → to ensure reliability  
• use of an annotation tool → to ease/speed up the annotation work 
• annotation characterization (e.g., semantic types, relations) based on the desired task → for better scope definition 
 
2 https://www.i2b2.org/NLP/DataSets/Main.php 
3 https://sites.google.com/site/shareclefehealth/ 
4 https://clear.colorado.edu/TemporalWiki/index.php/Main_Page 
5 https://cabernet.limsi.fr/annotation_guide_for_the_merlot_french_clinical_corpus-Sept2016.pdf 
     On the other hand, mostly because of annotation costs, issues associated to a high generalization and specificity of the annotation, 
and difficulties in obtaining clinical data, none of the available corpora shares all the following characteristics together:  
• documents from multiple institutions → different writing and care styles  
• multiple types of documents (e.g., discharge summaries, nursing notes) → distinct care phases 
• documents from various medical specialties (e.g., cardiology, nephrology) → broader clinical view and care perspectives 
• multiple medical conditions (e.g., diabetes, cardiovascular disease) →larger dictionary of terms 
• high granularity entity annotation (normally they grouped a few entity types) → enables specific labeling 
• shared a detailed annotation guideline → allows replication 
• a high number of clinical notes → more representativity and ML training conditions 
• outside English scope → boost research field in other languages 
     Although there is a lack of large multi-purpose corpora, it is also necessary to note the need for a heterogeneous clinical corpus for 
the scientific community. For example, Deleger et al. (2012)[37] argue that most of the clinical data de-identification systems were 
tested in corpora composed of a unique or small variety of document types (e.g., discharge summaries, nursing notes), when the ideal 
would be an evaluation using heterogeneous corpora. In addition, when defining the granularity of corpus annotation, one must re-
member the trade-off between granularity and reliability, as discussed by Crible and Degand (2017)[38], prioritizing each of these 
aspects according to the objectives of the annotation. 
     Hovy and Lavid (2010)[39] refer to corpus annotation as “adding interpretive information into a collection of texts,” and describe 
seven main questions in a general annotation project:  
1. Representative text selection 
2. Concept/Theory instantiation (tagset definition + guidelines first draft) 
3. Annotators selection and training (preliminary annotation + guidelines update) 
4. Annotation procedure specification (definitive guidelines) 
5. Annotation interface design (increase speed and avoid bias) 
6. Evaluation measures definition (satisfactory agreement level – in case of low agreement, returns to step 2 – if in good agree-
ment, continue annotation, maintaining intermediate checks, improvements, etc.) 
7. Annotation finalization and NLP/ML algorithm deployment 
     Xia and Yetisgen-Yildiz (2012)[14] listed the challenges and strategies in clinical corpus annotation, and concluded that the medi-
cal training of the annotators is not enough on its own to ensure that high-quality annotations will be achieved; as a result, NLP re-
searchers should get involved in the annotation process as early as possible. Moreover, compared to a typical annotation task, the use 
of physicians is much more expensive and difficult to schedule. Therefore, depending on the complexity/specialization of the clinical 
task, medical students might be an optimal alternative. 
     The reliability of an annotated corpus is another important aspect to be aware of. Most of the work relies on the inter-annotator 
agreement (IAA) calculation as the main metric to assess reliability. There are different methods used to calculate the IAA. Artstein 
and Poesio (2008)[40] surveyed most of them (e.g., observed agreement, Krippendorff’s alpha, Cohen’s kappa), and discussed their 
use in multiple annotation tasks. As pointed out by many researchers [13,37,41,42], Cohen’s kappa and other chance correction ap-
proaches (which are vastly used in classification tasks) are not the most appropriate measure for named entity annotation, because the 
probability of agreement by chance between annotators is nearly zero when one labels text spans. In addition to the method used to 
calculate the IAA, what value is considered good and represents a quality gold standard? Hovy and Lavid (2010)[39] state that the 
annotator manager needs to determine the acceptable IAA values based on its goals, and when it comes to using the corpus to train 
ML algorithms, one should aim to have enough data with realistic agreement values considering the desirable task.  
     In the medical area, a well-known and accepted convention for IAA “strength” values is the one proposed by Landis and Koch 
(1977)[43], in which 0.41<=IAA<=0.60 is moderate, 0.61<=IAA<=0.80 is substantial, and IAA>= 0.81 is almost perfect. 
Artstein and Poesio[40] claim that the adequate level of agreement for specific purposes is obscure, because different levels of agree-
ment may be good for one purpose and bad for another. They discussed Reidsma and Carletta’s (2008) work[44], in which the authors 
approach the reliability thresholds used in Computational Linguistics (CL), where IAA  0.8 is considered to be good and 0.8 > IAA 
> 0.67 is tolerable. The authors also demonstrate that ML algorithms can tolerate data with low-reliability values, and sometimes, 0.8 
reliability measures are not synonymous with good performance. In other words, agreement metrics are weak predictors of ML per-
formance. This agrees to an extent with the discourse in Roberts et al. (2009)[5], who stated, “The IAAs between double annotators 
that are given do not therefore provide an upper bound on system performance, but an indication of how hard a recognition task is.” 
3. Data preparation 
Our data are obtained from two different data sources: (1) a corpus of 2,094,929 entries from a group of hospitals in Brazil made in 
the period between 2013 and 2018, and (2) a corpus originating from a University Hospital based on entries made in the period be-
tween 2002 and 2007, which counts with 5.617 entries. In the first dataset, each entry has structured data (e.g., gender, medical spe-
cialty, entry date) and unstructured data in a free-text format, representing sections of a clinical narrative (e.g., disease history, family 
history, and main complaint). The data were obtained from the records of approximately 553,952 patients. 
     Besides the multi-institutional aspect of the corpus, it covers various medical specialties (e.g., cardiology, nephrology, and endo-
crinology) and clinical narrative types (e.g., discharge summaries, nursing notes, admission notes, and ambulatory notes). 
The second dataset has only one document type (i.e., discharge summaries) and comes from the Cardiology Service Center exclusive-
ly. The data configuration has structured data (i.e., gender, birth date, begin date, end date, and icd-10 code) and just one free-text data 
field, concerning the discharge summary. The texts from both datasets have some already known characteristics related to clinical 
narratives in general [45], such as uncertainty, redundancy (often due to copy and paste), high use of acronyms and medical jargon, 
misspellings, fragmented sentences, punctuation issues, and incorrect lower and uppercasing. Some text examples are presented in 
Table 1. The de-identification process is described in the “annotation tool” section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type/Specialty Original narrative Translated narrative  
Discharge 
summary 
Cardiology 
PACIENTE DIABÉTICA, HIPERTENSA, CARDIOPATIA ISQ. COM 
IMPLANTE DE STENT EM DAE EM JUL/03 INTERNOU COM 
QUADRO DE ANGINA INSTÁVEL. TRANSFERIDA PARA O 
SERV DE HEMODINÂMICA, REALIZOU CAT SENDO 
SUBMETIDA A ACTP EM LESÃO DE ÓSTIO DA SEGUNDA 
DIAGONAL. PROCEDIMENTO REALIZADO COM SUCESSO 
ANGIOGRÁFICO. RECEBE ALTA ASSINTOMÁTICA. Paciente ex-
tabagista, vem à emergência com quadro de dispnéia progressiva, ortop-
néia, dispnéia paroxística noturna, edema de membros inferiores, tur-
gência jugular. Diagnóstico de insuficiência cardíaca, com classe funci-
onal IV (NYHA) na chegada. Sem história de dor torácica. ECG da 
chegada sem alterações. Marcadores de necrose miocárdica normais. 
Manejado para insuficiência cardíaca com boa resposta clínica. Ecocar-
diograma demonstrando dilatação de cavidades (AE = 5,3 cm, DDVE = 
7,0, DSVE = 5,8), disfunção sistólica (FEVE = 35%) por hipocinesia 
difusa, septo e parede posterior de 0,9 cm, insuficiência mitral e tricús-
pide leves e PSAP = 52 mmHg. Realizado investigação etiológica com 
sorologia negativa para Chagas, cintilografia demonstrando necrose 
apical, sem condições de discriminar isquemia. Optado então pela reali-
zação de cateterismo cardíaco, que revelou artéria circunflexa dominan-
te e livre de lesões significativas; artéria coronária direita livre com 
sinais de aterosclerose, mas sem lesões significativas; artéria descenden-
te anterior de pequeno calibre, com lesão de cerca de 60% no terço 
proximal e lesão crítica no terço médio. Após revisão do filme, obser-
vou-se tratar de lesão de difícil manejo percutâneo, devido à sua exten-
são e ao pequeno calibre da artéria descrita. Após discussão do caso, 
optou-se por manejo clínico devido ao fato do paciente não apresentar 
angina, ter respondido com sucesso à terapêutica instituída e não apre-
sentar evidência clara de benefício atual com procedimento de revascu-
larização. Impressão de que a lesão em DAE não explicaria a hipocine-
sia difusa apresentada pelo paciente, devendo ser portanto doença ate-
rosclerótica coexistindo em um coração com miocardiopatia dilatada. 
Realizado ainda espirometria que evidenciou distúrbio obstrutivo mode-
rado. DCE estimada em 57 ml/min. Paciente recebe alta em bom estado 
geral, afebril, eupnéico, em otimização do tratamento para ICC (já em 
uso de betabloqueador, IECA e espironolactona), com plano de ajustes 
de doses a nível ambulatorial.  OBS: peso na alta: 76 Kg. 
DIABETIC PATIENT, HYPERTENSE, ISCHEMICAL 
CARDIOPATHY. WITH STENT IMPLANT IN LAD IN 
JUL / 03 HOSPITALIZED WITH SYMPTOMS OF UNSTABLE 
ANGINA. TRANSFERRED TO THE SERVICE OF 
HEMODYNAMIC, PERFORMED CATHETERISM, SUBMITTED 
TO PCTA IN THE SECOND DIAGONAL INJURY.  
PROCEDURE PERFORMED WITH ANGIOGRAPHIC SUCCESS. 
ASYMPTOMATIC HOSPITAL DISCHARGE. 
Ex-smoker patient comes to the emergency room with progressive 
dyspnea, orthopnea, paroxysmal nocturnal dyspnea, lower limb edema, 
and jugular turgence. Heart failure diagnosis, with functional class IV 
(NYHA) upon arrival. No history of chest pain. ECG on arrival without 
change. Normal myocardial necrosis markers. Managed for heart failure 
with good clinical response. Echocardiogram showing cavity dilatation 
(LA = 5.3 cm, LVDD = 7.0, LVSD = 5.8), systolic dysfunction (LVEF 
= 35%) due to diffuse hypokinesia, a 0.9 cm septum and posterior wall, 
mild mitral and tricuspid regurgitation, and APSP = 52 mmHg. Etiolog-
ical investigation with Chagas negative serology, scintigraphy showing 
apical necrosis, unable to discriminate ischemia. Then opted for cathe-
terization which revealed a dominant circumflex artery free of signifi-
cant lesions; free right coronary artery with signs of atherosclerosis but 
no significant lesions; small anterior descending artery with a lesion of 
about 60% in the proximal third and critical injury in the middle third. 
After review of the film, it was observed that it was a difficult percuta-
neous management injury owing to its extension and the small caliber of 
the described artery. After discussion of the case, we opted for clinical 
management because the patient did not have angina, successfully re-
sponded to the therapy instituted, and did not present clear evidence of 
being benefitted by the revascularization procedure. The impression that 
the lesion in LAD would not explain the diffuse hypokinesia presented 
by the patient; therefore, atherosclerotic disease coexisting in a heart 
with dilated cardiomyopathy. Accomplished yet spirometry that showed 
moderate obstructive disorder. DCE estimated at 57 ml / min. Patient is 
discharged in good general condition, afebrile, eupneic condition, opti-
mizing treatment for CHF (already using beta-blocker, ACEI and spiro-
nolactone), with outpatient dose adjustment plan. OBS: weight in the 
high: 76 Kg 
Ambulatory 
note 
Nephrology 
NEFROPATIA DIABETICA EM TTO CONSERVADOR 
CANDIDATA A TX RENAL PREEMPTIVO  
LIBERADA PELA URO E ANESTESIO  
CANDIDATA A TX RENAL PREEMPTIVO 
ASSINTOMÁTICA, EXCETO PELOS SINAIS E SINTOMAS 
ASSOCIADOS A NEUROPATIA PERIFERICA ( DIABETICA / 
UREMIA) 
SEM SINTOMAS URINARIOS 
AO EXAME PA 150/100  P 108 T 36 DIURESE FRR NORMAL 
HIPOCORADA + 
CPP LIVRES 
PC RITMO REGULAR, TAQUICARDICO 
ABD RHA+, PLANO, FLÁCIDO, CIC CX CST 
MMII PULSOS PRESENTES E SIMETRICOS 
DIABETIC NEPHROPATHY IN CONSERVATIVE TREATMENT 
Preemptive Kidney Transplant Candidate 
RELEASED BY UROLOGY AND ANESTHESIOLOGY 
Preemptive Kidney Transplant Candidate 
ASYMPTOMATIC, EXCEPT FOR SIGNS AND SYMPTOMS 
ASSOCIATED WITH PERIPHERAL NEUROPATHY (DIABETIC / 
UREMIA) 
NO URINARY SYMPTOMS 
ON EXAMINATION BP 150/100 HR 108 T 36 DIURESE RR 
NORMAL 
PALLOR + 
FREE LF 
CS REGULAR Rhythm, Tachycardic 
ABDOMEN RHA +, FLAT, FLAT, CIC CX CST 
LLLL PRESENT AND SYMMETRICAL PULSES 
Nursing note 
Not defined 
Pcte com RNM de crânio agendada para hoje às 23:00h. Por volta das 
21:00h pcte apresentou quadro de confusão mental , seguida de crise 
convulsiva generalizada , prontamente atendido na sala de poli , com 
MCC + oximetria digital de pulso + PNI contínuos . Instalado O2 , 
medicado CPM e  mantido em observação no leito . Hidantalizado pela 
R1 Vital Brasil da neurocirurgia , procedimento realizado sem intercor-
rências . Pcte bastante sonolento , mantido em sala de poli e suspenso 
RNM por hora . Diurese espontânea , com controle através de uropen . 
SSVV às 05:45h PA = 133/74mmhg , FC = 114bpm, SpO2 = 93% .  
Conforme orientação da neurocirurgia , mantém observação na sala de 
poli sob cuidados intensivos de enfermagem .   CHOQUE NAO 
ESPECIFICADO 
Patient Skull MRI scheduled today at 23:00. At around 21:00, the pa-
tient presented with mental confusion, followed by generalized seizure, 
promptly treated in the multiple trauma room, with MCC + digital pulse 
oximetry + continuous NIBP. Installed O2, medicated as prescribed and 
kept under observation in bed. Hidrantalized by R1 Vital Brasil of neu-
rosurgery, procedure performed without complications. Very sleepy 
patient kept in emergency room and suspended MRI for hour. Sponta-
neous diuresis, with uropen control. VVSS at 05:45 h BP = 133 / 74 
mmhg, HR = 114 bpm, PsO2 = 93%. As directed by neurosurgery, 
maintains observation in the emergency room under intensive nursing 
care. SHOCK NOT SPECIFIED 
 
Table 1. Samples of different types of clinical narratives from our corpus. 
3.1 Document selection 
The original and main focus of the intended semantic annotation was two-fold: (i) to support the development of a NER algorithm to 
be used in a summarization method and (ii) to evaluate a semantic search algorithm, both focusing on cardiology and nephrology spe-
cialties. Thus, we selected almost 500 clinical notes from both medical specialties (including two patients’ complete longitudinal rec-
ords). Owing to the lack of corpora for pt-br, we decided to increase the scope of study to support other bio-NLP tasks and medical 
specialties. We randomly selected documents from other medical areas to complete 1,000 clinical narratives, assuming that the data 
are satisfactorily consistent and representative to train an ML model. Table 2 shows the number of documents per specialty. The aver-
age character token size was ~148 and the average sentence size was approximately 10 tokens. 
 
Specialty Number 
Cardiology 260 
Nephrology 157 
Orthopedy 126 
Not defined 122 
Surgery (general) 61 
Neurology 45 
Neurosurgery 32 
Dermatology 23 
Ophthalmology 22 
Endocrinology 19 
Gastroenterology 16 
Otolaryngology 14 
Pneumology 11 
Others 92 
Table 2. Medical specialties frequency table 
 
Note that several documents are assigned as “Not defined,” because this is one of the majority classes in the corpus we received. Nev-
ertheless, by looking at these documents, we can conclude that these patients are (a) under the care of multiple medical specialties 
(e.g., patient with multiple trauma, in ICU) or (b) in the middle of a diagnostic investigation. Moreover, we grouped the specialties 
with less than 10 documents as “Others” (e.g., urology, oncology, gynecology, rheumatology, proctology). 
3.2 Text organization 
In Table 3, we present the available data in each entry of the database (concerning our first and main data source). To have a unique 
text file per entry, we concatenated all free-text fields into a single text document to be annotated.  
     Besides the already known issues in clinical text, our database has other issues. The medical staff is supposed to write the patient's 
clinical note in all the free-text fields. The EHR application has one textbox for each field, and these sections serve as the clinical nar-
rative sections. However, as most of the clinicians enter all the text in the history-of-disease field only, with the others remaining 
empty, making it difficult to search for specific information in the narrative (e.g., look for family history). Additionally, some text is 
written completely in upper case letters and interfering directly in some text processing, such as finding abbreviations and identifying 
proper nouns. 
 
Field Data type 
occurrence-id Number 
patient-id Number 
gender Text 
birth-date Date 
inclusion-date Date 
discharge-date Date 
discharge-type Text 
discharge-reason Text 
icd-10 Text 
medical-specialty Text 
care-reason Text 
main-complaint Free-Text 
history-of-disease Free-Text 
past-history Free-Text 
family-history Free-Text 
physical-examination Free-Text 
main-diagnosis-hypothesis Free-Text 
initial-plan Free-Text 
observations Free-Text 
Table 3. Database entry data configuration 
4. Annotation schema 
In this section, we describe the entire annotation schema, including the conception and evolution of the annotation guidelines, the de-
velopment of a tool to support and improve the annotation workflow, and finally an overview of the annotation process and its exper-
imental setup. The steps that were followed consider the lessons learned from other similar annotation projects reviewed in section 2. 
4.1 Annotation guidelines 
To ensure the quality of a gold standard, it is crucial to maintain the homogeneity of annotation during the entire process. To provide 
guidance to annotators and answer their possible questions, we defined a set of guidelines, in which we explained, in detail, how to 
annotate each type of concept and showed examples of what should be annotated and what should not.   
     The first step was to define which information we wanted to annotate within the text. Regarding the clinical concepts, we opted to 
use the UMLS semantic types6 (STY) as our annotation tags (e.g., “Body Location or Region,” “Clinical Attribute,” “Diagnostic Pro-
cedure,” “Disease or Syndrome,” “Finding,” “Laboratory or Test Result,” “Sign or Symptom,” and “Therapeutic or Preventive Proce-
dure”). Table 4 presents some of the most used STYs with examples.  
     We decided to use the UMLS STYs because we needed a high granularity annotation, as we wanted a ground-truth to evaluate a 
semantic search algorithm that labels entities using the STYs (more than a hundred types). We assumed the risk of agreement loss 
(owing to the reliability and granularity trade-off discussed in section 2), but, at the same time, with greater coverage of the concepts 
in the corpus, the gold standard could be utilized in a higher number of bio-NLP tasks. Even when the task has a low granularity ap-
proach, it is possible to export the actual annotations to their corresponding UMLS semantic groups7 (SGR). The second reason for 
our use of the UMLS STYs relies on the UMLS Metathesaurus resource, which can serve as an important guide to annotators, as they 
can search for a specific concept to make sure of the STY they are annotating. 
 
 
 
 
 
 
 
6 https://www.nlm.nih.gov/research/umls/META3_current_semantic_types.html 
7 https://metamap.nlm.nih.gov/SemanticTypesAndGroups.shtml 
SGR STY Original examples Translated examples 
Anatomy Body Location or 
Region 
MEIA TALA GESSADA EM MIE 
apresenta edema em região craniana 
ABDÔMEN PLANO E FLÁCIDO 
Half-length plaster cast in LLL 
presents edema in the cranial region 
FLAT AND FLACID ABDOMEN 
Anatomy Body Part, Organ, or 
Organ Component 
acesso venoso central em jugular D 
ACESSO VENOSO PERIFERICO EM 
BRAÇO DIREITO 
right jugular central venous access 
RIGHT ARM PERIPHERAL VENOSOUS 
ACCESS 
Chemicals & 
Drugs 
Organic Chemical Fez uso de atenolol por 3 anos 
cefaléia em regiao parietal bilateral que me-
lhora com dipirona 
used atenolol for 3 years 
headache in bilateral parietal region im-
proved with dipyrone 
Chemicals & 
Drugs 
Pharmacologic Sub-
stance 
asmatica em uso de salbutamol e budesonida asthmatic person using salbutamol and 
budesonide 
Concepts & 
Ideas 
Temporal Concept POI DE LAVAGEM + CURETA DE 
TECIDO NECRÓTICO 
Paciente em Pré-operatório de FX fêmur 
WASHING IP + NECROTIC TISSUE 
CURETAGE 
Preoperative patient of femur fracture 
Devices Drug Delivery De-
vice 
cloreto de potassio a 42 ml/h em bomba de 
infusão 
potassium chloride at 42 ml/h in infusion 
pump 
Devices Medical Device AVP em MSE com soroterapia em curso 
SVD com diurese efetiva 
PVA in LUL with ongoing serotherapy 
DBP with effective diuresis 
Disorders Disease or Syn-
drome 
REFERE HIPERTENSÃO E DIABETES 
EM USO DE INSULINA. 
SINDROME DE GUILLAIN BARRE. 
REFERS HYPERTENSION AND 
DIABETES IN INSULIN USE 
GUILLAIN BARRE SYNDROME 
Disorders Finding RETORNOU DO CC LÚCIDO, 
ORIENTADO, COMUNICATIVO 
consciente, comunicativo, pupilas isocóricas 
fotoreagentes 
RETURNED LUCID FROM SC 
CONSCIOUS, COMMUNICATIVE 
conscious, communicative, photoreagent 
isochoric pupils 
Disorders Injury or Poisoning TRAUMA CRÂNIOCERVICAL APÓS 
QUEDA 
FRATURAS MULTIPLAS DA COLUNA 
TORACICA. 
SKULL-CERVICAL TRAUMA AFTER 
FALL 
MULTIPLE FRACTURES IN THORACIC 
COLUMN  
Disorders Sign or Symptom relata cefaléia 
SINAIS VITAIS ESTAVÉIS, REFERE 
ALGIA 
reports headache 
STABLE VITAL SIGNS, REFERS PAIN 
Living Be-
ings 
Patient or Disabled 
Group 
paciente nega queixas, nega dor, dispnéia. 
 
Pcte com cultura de Secreção Tibial 
patient denies complaints, denies pain, dysp-
nea. 
Ptt with Tibial Secretion culture 
Living Be-
ings 
Professional or Oc-
cupational Group 
Orientada a equipe de enfermagem que o 
mesmo esta em jejum 
segundo a farmacêutica e o médico 
Advised nursing staff that the patient is fast-
ing 
according to the pharmacist and the doctor 
Organizations Health Care Related 
Organization 
CONFORME ROTINA DA UTI 
RETORNOU DO CC ÀS 14:30HRS 
AS ICU ROUTINE 
RETURNED FROM SC AT 2:30pm 
Phenomena Laboratory or Test 
Result 
Glicose 335; LDH 223; 
Teste rápido para HIV negativo 
Glucose 335; LDH 223; 
HIV negative rapid test 
Physiology Clinical Attribute PA = 130/70 
PESO 67,4 
BP = 130/70 
WEIGHT 67.4 
Procedures Diagnostic Proce-
dure 
AUSCULTA PULMONAR; MV +, 
RONCOS DIFUSOS EM BASES 
Monitorização cardíaca contínua, PAM e 
oximetria digital. 
PULMONARY AUSCULTATION; VM +, 
DIFFUSED WHEEZES IN BASES 
Continuous cardiac monitoring, MAP, and 
digital oximetry. 
Procedures Health Care Activity EM ACOMPANHAMENTO NA 
ENDOCRINO DO HC 
Internamento em janeiro por taquicardia atri-
al com aberrância 
FOLLOW-UP ON ENDOCRINOLOGY AT 
HC 
Admission in January for aberrant atrial 
tachycardia 
Procedures Therapeutic or Pre-
ventive Procedure 
SVD COM 100 ML DEBITO SEM 
GRUMOS 
IRC EM DIALISE 
DC WITH 100 ML DEBIT WITHOUT 
GROUNDS 
CRF IN DIALYSIS 
N/A Abbreviation CONFORME ROTINA DA UTI[Unidade de 
Terapia Intensiva] 
MEIA TALA GESSADA EM MIE[Membro 
inferior esquerdo] 
AS ICU[Intensive Care Unit] ROUTINE  
 
Half-length plaster cast in LLL [Lower left 
limb] 
N/A Negation Paciente eupnéico e afebril 
Paciente nega algia 
SEM IRRADIAÇAO 
Eupneic and feverless patient 
Patient denies pain 
NO IRRADIATION 
Table 4. Text samples containing the most used STYs. The underlined passages indicate the annotated concepts. 
      
     Moreover, the UMLS REST API8 allows our annotation tool to automatically suggest the STY for some clinical concepts. Fur-
thermore, as two important bio-NLP tasks are not covered by the STYs, we added two more types in our tagset, the “Negation” and 
“Abbreviation” tags. The first one aims to identify negation cues associated with clinical concepts (already tested in a negation detec-
tion algorithm presented in a later section). The “Abbreviation” type was incorporated to help us in the process of abbreviation disam-
biguation. Sometimes, when we want to extract semantic meaning from clinical text, the semantic value of a concept alone is not 
enough to infer important events and situations. Hence, we incorporated the annotation of relations between clinical concepts to the 
guidelines. The relation annotation schema was partially derived from the UMLS Relationships Hierarchy. Unlike the concept sche-
ma, we decided to use a restricted set of tags; therefore, instead of 54 UMLS relationship types, we used only one to simplify the rela-
tion annotation (as it was not our main focus). The RTYs included only the “associated_with” and “negation_of” (not a UMLS RTY; 
it was added to complement the Negation STY) RTYs. There are five major non-hierarchical RTYs (i.e., conceptually_related_to, 
functionally_related_to, physically_related_to, spatially_related_to, temporally_related_to) that connect concepts by their semantic 
values. We represent them by using their parent RTYs only, the “associated_with” RTY. Depending on the chosen STY, it is possible 
to infer the sub-types of “associated_with” automatically. Once the concepts and relationships were defined, an annotation script was 
established, in which the annotator should first label all the concepts and then annotate the relations. We followed this order because 
Campillos et al. (2018)[4] found that the agreement between annotators was higher when annotating was performed this way.  
     Deleger et al. (2012)[37] stated that the most difficult STY to annotate was “Finding,” because it is a very broad type that can cor-
respond to signs/symptoms (e.g., “fever”), disease/disorders (e.g., “severe asthma”), laboratory or test results (e.g., “abnormal ECG”), 
and general observations (e.g., “in good health”). To avoid disagreements, we decided to simplify the definition of “Finding.” Annota-
tors should always give preference to disease/disorders and lab results STY’s over the “Finding” STY. Only results of physical exam-
ination considered to be normal should be marked as “Finding” (e.g., “flat abdomen” and “present diuresis”). The abnormal ones 
should be labeled as “Sign or Symptom”. We know that this can cause discrepancies between UMLS concepts and our annotation, but 
it makes more sense for our task. Using these definitions, we prepared the first draft of the guidelines, which was given to the annota-
tors. Furthermore, we provided training that acquainted them with the annotation tool and allowed them to realize some of the diffi-
culties in the process. Then, an iterative process was started to enhance the guidelines, and check the consistency of annotation be-
tween annotators (more details on Inter Annotator Agreement in the Results section), and provide feedback on their work. We as-
sumed that, if in 3 consecutive rounds the agreement stayed stable (no significate reduction or improvement), there was no room for 
guideline adaptation, and the final annotation process could be initiated. A flowchart of the process is given in Figure 1, and it is simi-
lar to what Roberts et al. (2009)[5] and others used. 
 
 
Figure 1. Revision and quality verification process of the annotation guidelines 
 
8 https://documentation.uts.nlm.nih.gov/rest/home.html 
 4.2 Annotation tool 
The previously discussed issues and difficulties related to clinical annotation indicate that we needed an annotation tool that can ease 
and accelerate the annotators’ work. We analyzed Andrade et al.’s (2016)[46] review on annotation methods and tools applied to clin-
ical texts and decided to build our own tool. This approach ensured that all annotators could share the same annotation environment in 
real-time and work anywhere/anytime without technical barriers (i.e., web-based application). Furthermore, the project manager could 
better supervise and organize all the work and assign the remaining work to the persons involved. Moreover, as we used UMLS se-
mantic types in our scheme, it would be desirable to use the UMLS API and other local resources (e.g., clinical dictionaries) support-
ing the text annotation by making annotation suggestions to the user without pre-annotating it. Finally, we needed a tool that fitted 
exactly into our annotation workflow, with the raw data input into our environment, and a gold standard output at the end of the pro-
cess, dispensing the use of external applications. Our tool workflow was composed of six main modules: 
• Importation: import data files into the system 
• Review: manually remove PHI information that the anonymization algorithm failed to catch 
• Assignment: allocate text to annotators 
• Annotation: allow labeling of the clinical concepts within the text with one or multiple semantic types, supported by the An-
notation Assistant feature 
• Adjudication: resolve double-annotation divergences and creation of the gold standard 
• Exportation: exports the gold standard as JSON or XML 
     The aforementioned Annotation Assistant component was developed to prevent annotators from labeling all the text from scratch 
by giving them suggestions of possible annotations based on (a) previously made annotations and (b) UMLS API exact-match and 
minor edit-distance lookup. Further details on technical aspects, modules functionalities, and experiments showing how the tool af-
fects the annotation time and performance are reported on [47]. 
4.3 Annotation process 
Besides the advice and recommendations found in section 2, similar to Roberts et al. (2009)[5], we decided to follow a well-known 
annotation methodology standard [48]. Furthermore, we added a guidelines agreement step, in which all the text was double-
annotated with the differences resolved by a third experienced annotator (i.e., adjudicator), and documents with low agreement were 
not included in the gold standard. Pairing annotators to perform a double annotation of a document prevents bias caused by possible 
mannerisms and recurrent errors of a single annotator. Moreover, it is possible to check the annotation quality by measuring the 
agreement between both annotators. 
     It is almost impossible to achieve an absolute truth in such an intricate annotation effort like this one. To reach as close as possible 
to a consistent ground-truth, we adopted the use of an adjudicator, who was responsible for resolving the differences between the an-
notators. It is worth mentioning that the adjudicator cannot remove annotations made by both annotators, and neither create new anno-
tations, hampering a gold standard made with the opinion of a single person. After the guideline maturing process, we started the final 
development stage of the gold standard, which posteriorly was divided into ground-truth phases 1 and 2. We decided to recruit anno-
tators with different profiles and levels of expertise to give us different points of view during the guideline definition process, and to 
determine if there were differences in annotation performance between annotators with different profiles. 
     Ground-truth phase 1 counted with a team of three persons: (1) a physician with experience in documenting patient care and par-
ticipation in a previous clinical text annotation project; (2) an experienced nurse; and (3) a medical student who already had ambulato-
ry and EHR’s use experience. The nurse and the medical student were responsible for the double-annotation of the text, and the physi-
cian was responsible for adjudicating them. When the process was almost 50% complete (with 496 documents annotated and adjudi-
cated), we managed to engage more people to assist in finishing the task (in what we called ground-truth phase 2). An extra team of 
6 medical students, with the same background as the first one, were recruited (Figure 2 illustrates these phases). We held a meeting in 
which we presented the actual guidelines document and trained them on using the annotation tool. 
     In phase 2, we had two adjudicators, the physician, and the nurse. We added the nurse as an adjudicator as we needed one extra 
adjudicator during this phase, and the nurse had more hospital experience than medical student 1. Then, we had a homogeneous group 
of seven medical students annotating the texts. The physician, the nurse, and medical student 1 supervised the first set of annotations 
of all the students. The number of documents to be annotated were divided equally between the annotators and adjudicators, and the 
selection of double-annotators for each document was made randomly, as was done for the adjudicators. It is worth noting that besides 
the people mentioned above, who worked directly with annotation and adjudication, we had a team of Health Informatics researchers 
who participated in supporting the annotation project with other activities, including annotation tool development, guidelines discus-
sion, and annotation agreement feedback. 
 
Figure 2. Annotation process overview, including ground-truth phases 1 and 2, which are located above and below the dashed line, respectively. 
 
4.4 Corpus reliability and segmentation 
Taking advantage of the fact that we had double-annotated the entire collection of documents, we calculated the IAA of all the data 
using the observed agreement metric, as presented in the following equation (no need for chance-correction calculations, as described 
in section 2). For the strict version of IAA, a situation was considered a match, when the two annotators label the same textual span 
with an equal semantic type. All other situations were calculated as a non-match. We reported the lenient version of IAA as well, 
which considers partial matches, that is, the annotations that have overlaps in the selected textual spans (with the same STY); these 
are counted as a half-match in the formula. The third version of IAA, called flexible, was calculated. We transformed the annotated 
STY to its corresponding SGR (e.g., “Sign or Symptom,” “Finding,” and “Disease or Syndrome” STYs are converted to the “Disor-
der” SGR). Then, we performed a comparison to determine whether the SGRs are equal (the textual span needs to be the same). Final-
ly, the fourth version of IAA was relaxed, i.e., we considered partial textual spans (overlaps) and SGRs at the same time. 
𝐼𝐴𝐴 =  
𝑚𝑎𝑡𝑐ℎ𝑒𝑠
𝑚𝑎𝑡𝑐ℎ𝑒𝑠 + 𝑛𝑜𝑛_𝑚𝑎𝑡𝑐ℎ𝑒𝑠
 
     To isolate the concept agreement scores from the relationship score, we reported the relationship IAA values by considering only 
those relationships in which both annotators labeled two of the connected concepts. Otherwise, if an annotator did not find one of the 
concepts involved, the relationship IAA would be directly penalized. 
     Boisen et al. (2000)[48] recommend that only documents with an acceptable level of agreement should be included in the gold 
standard, and we followed their recommendation. However, because of the scarcity of this kind of data in pt-br bio-NLP research, and 
as the limited amount of annotated data is often a bottleneck in ML [49], we did not exclude documents from our corpus, but opted to 
segment it in two, namely gold and platinum. This division was made based on the IAA values of each annotated document, where 
documents with an IAA greater than 0.67 belong to the gold standard and all the other ones to platinum. We picked the 0.67 thresh-
old because is the one Artstein and Poesio (2008)[40] discussed to be a tolerable value. Additionally, we think the 0.8 threshold is 
rigorous considering the complexity of our task and the number of persons involved in it. The task complexity is explained by the 
heterogeneity of the data, which are obtained from multiple institutions, various medical specialties, and different types of clinical 
narratives. The study that comes closest in data diverseness to ours is Patel et al. (2018)[30], with the exception that their data come 
from a single institution. Moreover, despite the large amount of data they used, there are differences between their study and ours; for 
example, they used a coarse-grained annotation scheme by grouping the STYs, which made the labeling less prone to errors. Moreo-
ver, we believe that a great portion of errors that caused disagreements came from repeated mistakes on the part of one annotator in 
the pair, and owing to this, the error could be easily corrected by the adjudicator, as the examples in the following sections reveal. 
5. Annotation results and analysis 
This section compiles quantitative and qualitative results regarding our corpus development. We detail the IAA information used to 
segment the corpus and analyze the errors found during the annotation. Finally, we introduce and present the results of two bio-NLP 
applications that had already used the current corpus in their development. 
5.1 Corpus statistics 
The corpus development involved 8 annotators, 2 adjudicators, and 4 Health Informatics researchers, totaling a team of 14 people. 
Our corpus comprehended 100 UMLS semantic types representing the entities, 2 extra semantic types typifying Abbreviations and 
Negations, and 2 relationship types defining the relations between clinical entities. The annotation process was 100% double-
annotated and adjudicated, and lasted 14 months, resulting in a corpus composed of 1,000 documents (148,033 tokens), with 65,129 
entities and 11,263 relations labeled. In Table 5, we present the corpus size, considering the gold/platinum divisions. Tables 6 and 7 
show the number of annotations per STY and RTY. 
 
5.2 Inter annotator agreement 
We calculated the average agreement between all the 1,000 double-annotated documents in the corpus using four different IAA ver-
sions for the concepts (i.e., strict, lenient, flexible, and relaxed) and the regular version for relations. We achieved an average strict 
IAA of ~0.71 and ~0.92 for the relaxed version in the concept annotation task. For the relations, the IAA was ~0.86. In Table 8 we 
detail the average IAA values for the entire corpus, and Figure 3 presents the average agreement considering the most frequent STYs. 
Table 9 shows the IAA per RTY. 
     The results reveal that even with a complete annotation environment, composed by a refined set of guidelines, use of a personal-
ized annotation tool, clinically trained annotators, and constant reliability analysis, it is extremely difficult to reach a perfect agree-
ment. Overall, we believe that we built a good quality corpus, with IAA values comparable to other clinical semantic annotation stud-
ies if we consider the specificities of it (described later in this section). It is worth noting that some other studies evaluated their cor-
pus by calculating the agreement between annotators and adjudicators, which typically produces superior agreement numbers when 
compared to IAA. This event can be seen in Bethard et al. (2016)[27], who achieved a 0.73 IAA and 0.83 annotator-adjudicator 
agreement. Another important detail is that we double-annotated 100% of our documents, not just portions of the corpus like most of 
the related work, which affects the final results as below average agreement values appear during certain project phases (e.g., because 
of a new annotation team or guidelines changes), and makes us believe that we have a clear and trustworthy view of the homogeneity 
of our corpus. 
 
Segment Documents Entities Relations 
Gold 613 41,588 7,344 
Platinum 387 23,541 3,919 
TOTAL 1,000 65,129 11,263 
Table 5. Corpus size considering gold and platinum divisions 
 
     The IAA scores by STYs (shown in Figure 3) corroborate with other authors regarding the difficulty difference between entity 
types. For example, “Disease or Syndrome” strict IAA was ~0.67 and “Pharmacologic Substance” was ~0.88, probably because the 
first one is composed mainly of multi-word expressions and the second one of single tokens. The agreement calculation used “less 
exact” approaches (considering SGRs over STYs) because there was a need to compare our results with those of other clinical seman-
tic annotation studies that grouped the label categories in a few coarse-grained types, like the MERLOT, MiPACQ and MedAlert cor-
pora [4,32,34]. Our approach allows the annotator to use all the semantic types of UMLS, which are more error-prone, particularly if 
we consider STYs in the same branch of the UMLS hierarchy tree (e.g., “Sign or Symptom” and “Finding”). We want to emphasize 
that, besides the granularity issue, our corpus development faced other challenges regarding its complexity. Using documents from 
multiple institutions brings to light some extra difficulties, like dealing with different text formats due to specific institutional work-
flows and new sets of local abbreviations/acronyms to be aware of. To the best of our knowledge, no other clinical annotation study 
has covered documents from multiple institutions. 
 
SGR STY Entities 
Anatomy Body Location or Region 1,452 
Anatomy Body Part, Organ, or Organ Component 1,373 
Chemicals & Drugs Organic Chemical 2,000 
Chemicals & Drugs Pharmacologic Substance 3,013 
Concepts & Ideas Quantitative Concept 3,953 
Concepts & Ideas Qualitative Concept 500 
Concepts & Ideas Temporal Concept 1,663 
Devices Medical Device 1,617 
Disorders Disease or Syndrome 2,650 
Disorders Finding 6,867 
Disorders Injury or Poisoning 521 
Disorders Sign or Symptom 4,707 
Living Beings Patient or Disabled Group 844 
Living Beings Professional or Occupational Group 720 
Organizations Health Care Related Organization 639 
Phenomena Laboratory or Test Result 3,079 
Physiology Clinical Attribute 1,128 
Procedures Diagnostic Procedure 2,012 
Procedures Health Care Activity 2,763 
Procedures Therapeutic or Preventive Procedure 4,791 
N/A Abbreviation 12,629 
N/A Negation 2,676 
Table 6. Number of annotations per STY for the entire corpus - considering the most frequent STYs 
 
RTY Relations 
associated_with 9,693 
negation_of 1,570 
Table 7. Number of annotations per RTY for the entire corpus 
 
IAA type IAA 
Strict (full span + STY match) 0.708 
Lenient (partial span + STY match) 0.834 
Flexible (full span + SGR match) 0.774 
Relaxed (partial span + SGR match) 0.921 
Table 8. Average IAA values for the entire corpus 
 
 
     Handling documents from multiple medical specialties (e.g., Endocrinology, Dermatology) makes the annotators’ training and ab-
straction significantly more difficult. Because with every new document they annotate, the chance to find new challenging, ambigu-
ous, and exception cases is higher than if they tackle documents covering topics in a single medical specialty. The CLEF corpus[5] 
scope, for instance, covered only narratives from patients diagnosed with neoplasms. The document type diversity could also influ-
ence the annotation process, as the documents are produced in different moments during the care workflow and are written by distinct 
medical professionals (physician, nurse, medical student, or intern); this can sometimes cause interpretation problems owing to their 
different perspectives.  
 
Figure 3. Average IAA values for the most frequent STYs 
 
RTY IAA 
associated_with 0.823 
negation_of 0.914 
Table 9. Average IAA values per RTY 
 
     Taking into account all those challenges and particularities of our corpus, we compared our results with previous initiatives and 
compiled the IAA values of entity and relation annotation of each corpus (see Table 10). The IAA percentage difference for entity 
annotation are ranging from 2.8% and 18.3% using the strict match, and 3.6% to 23.2% for lenient match. Except for MiPACQ, all the 
other corpora had better IAA values in strict match, probably due to the issues mentioned previously in the section. However, when 
we compare the lenient match scores, our performance is better than all other corpora except IxaMed-GS that had the best results of 
all of them. This led us to believe that our annotators had more trouble in defining the correct text spans than the ones in other projects 
because when we use a partial span match approach our results improved by 16.9% (from 0.71 to 0.83), and the other corpora im-
provement ranged from 3.8% and 8.6%. We are not sure if the cause of this is the lack of proper guideline definition, annotators expe-
rience or even the document types we used (examples of annotation span issues are detailed in the next section). 
     If we use the flexible and relaxed match instead of strict and lenient for entity annotation, our result goes from 0.71 to 0.77, and 
0.83 to 0.92 respectively, and in that setting, we think we have a fairer evaluation, because the corpus granularity and complexity is 
more similar to the other works, and then, our results comes closest to the others. Compared to CLEF corpus we achieved the same 
IAA for strict vs flexible and increased by 13% the results for lenient vs relaxed. MERLOT and MedAlert had slightly better results 
(2.6% and 3.9% respectively). IxaMed-GS still have a 9.1% advantage for strict vs flexible, maybe because it is the most specific and 
least in-depth corpus compared to others, but even so, it has a 2.2% disadvantage for lenient vs relaxed. And finally, we exceeded 
MiPACQ’s results by 10.4% and 18.5% using flexible and relaxed approaches. 
     For relation annotation, the scenario is completely different from entity annotation, as we used a simpler set of relations compared 
to other corpora (except IxaMed-GS that used only two relation categories as we did), and probably because of that, we achieved the 
better results for relation annotation, with the percentage difference ranging from 4.6% to 23.2%. 
 
Corpus Type Strict Lenient Flexible Relaxed 
CLEF [5] 
entities 0.77 (8.5%) 
 
0.80 (-3.6%) 0.77 (0%) 0.80 (-13.0%) 
relations - 0.75 (-12.7%) - - 
IxaMed-GS [13] 
entities 0.84 (18.3%) 0.90 (8.4%) 0.84 (9.1%) 0.90 (-2.2%) 
relations - 0.82 (-4.6%) - - 
MERLOT [4] 
entities 0.79 (11.2%) - 0.79 (2.6%) - 
relations - 0.78 (-9.3%) - - 
MedAlert [34,50] 
entities 0.80 (12.6%) - 0.80 (3.9%) - 
relations - 0.66 (-23.2%) - - 
MiPACQ [32] 
entities 0.69 (-2.8%) 0.75 (-9.6%) 0.69 (-10.4%) 0.75 (-18.5%) 
relations - - - - 
Table 10. Comparison between similar clinical annotation projects. In parentheses, the percentage difference in performance compared to our cor-
pus. Note that the IAA values for Flexible and Relaxed match are a copy of Strict and Lenient scores because the other authors did not calculate 
these metrics and we wanted to know the percentage difference between their values and ours. 
5.3 Error analysis 
The error (or disagreement) analysis showed the most common errors that have impacted the agreement results, and it was performed 
by the Health Informatics team continuously during the annotation process so that the annotators would be given feedback on their 
work. As performing a full error analysis for the entire corpus would be highly time-consuming, we only analyzed the part of the doc-
uments in which agreement had not reached the 0.67 IAA threshold. Moreover, the adjudicators were already aware of the persistent 
errors. As expected, a large number of errors occurred at the beginning of the annotation phases (i.e., ground-truth phases 1 and 2), 
because despite the training, the annotators were still getting used to the annotation process and using the guidelines document. An-
other common aspect of most of the disagreements is that they are not conceptual, that is, the disagreement does not originate from 
the semantic value given to the clinical entity, but rather from the different word span selection (term boundaries) normally associated 
with omission or inclusion of non-essential modifiers and verbs to a term (e.g., “o tratamento” vs “tratamento” labeled as “Therapeu-
tic or Preventive Procedure” – “the treatment” vs “treatment”). 
     The STYs high granularity caused two types of annotation divergences. The first one was with regard to the annotation using dif-
ferent STYs with close semantic meaning because they are directly related in the UMLS hierarchy. One of the most occurring errors 
of this type is related to “Finding” and “Sign or Symptom”, even with the simplification that we stated in our Guidelines that says: 
annotators should always give preference to disease/disorders and lab results STY’s over the “Finding” STY. Only results of physical 
examination considered to be normal should be marked as “Finding”. The abnormal ones should be labeled as “Sign or Symptom”. 
Another example of this kind of error is when the annotators should decide between “Medical Device” and “Drug Delivery Device”  
like with the “infusion pump” device. The second type of error associated with the high granularity occurred because some uncommon 
concepts could be labeled with some infrequent STYs not remembered by the other annotator (e.g., “Element, Ion, or Isotope”, “Age 
Group”, “Machine Activity”).  
     Erroneous decomposition of multiword expressions occurred even with many examples explicitly described in the guidelines. This 
error occurred when one annotator thought a compound term should be labeled as a single annotation and the other annotator as two 
or more different terms (annotations). There was no unique rule to follow in this case, as it depends on the context. Perhaps this is the 
reason for this type of error. For instance, the term “Acesso venoso central direito” (“right central venous access”) needs to be de-
composed as “right” (Spatial concept) and “central venous access” (Medical Device), but some annotators simply annotated all the 
term as “Medical Device”. And other terms do not need to be decomposed as “DRC estágio V” (“Chronic kidney disease stage 5”) 
that must be annotated as “Disease or Syndrome”. 
     We found some errors caused by the ambiguity of certain words that could misinterpreted in its sense, this happened mainly in 
abbreviations. For instance, “AC” could be “ausculta cardíaca”, “anticorpo” or “ácido” – “cardiac auscultation”, “antibody” or “ac-
id”). The term “EM” that could be “Enfarte do miocárdio”, “Esclerose múltipla” or “Estenose mitral” – “Myocardial infarction”, 
“Multiple sclerosis” or “Mitral stenosis”. We found simple omission errors of some concepts during the analysis as well.  
      In summary, the STYs performance (Figure 3) reflects the complexity of each STY, for example, the “Pharmacologic Substance” 
is composed mainly of single-word terms, and “Patient or Disable Group” has just a few terms encompassed by it, explaining their 
high IAA scores. Unlike “Finding” and “Sign or Symptom” for instance, that have a high frequency and very similar interpretations. 
5.4 Bio-NLP tasks application 
The functionality of an annotated corpus can be tested by applying it in a downstream NLP task. This section provides a brief over-
view of two bio-NLP studies that already used the corpus presented in this work to train an ML algorithm. The main objective is to 
prove the consistency and usefulness of our corpus as a rich resource for pt-br clinical tasks and not to present a state-of-the-art algo-
rithm. 
5.4.1 Negation detection 
One constant subject in bio-NLP research is the negation detection, which is often a prerequisite in information extraction tasks be-
cause of its important role in biomedical text (e.g., defining the presence or absence of a disease for a patient). Dalloux et al. (accept-
ed/in press manuscript)[51] proposed a cross-domain and cross-lingual negation and scope detection method, in which they used a 
supervised learning approach supported by a BiLSTM-CRF model with a pre-trained set of Word Embeddings. To train and assess 
their method in the pt-br clinical scope, they used a segment of our corpus with the negation-related annotations. This includes not 
only the negation cue labeled with the “Negation” STY, but the concepts related to it using the relation “Negation_of” so that detect-
ing the negation scope would be possible. They achieved a 96.22 F1 score for negation cue detection. Regarding the negation scope 
detection, they achieved an 84.78 F1 score for a partial match and 83.25 for an exact match.  
5.4.2 Clinical named entity recognition 
One of the most important abilities of bio-NLP is to identify and extract clinical entities within the text. This kind of algorithm (i.e., 
NER) can support so many types of methods, such as medical concepts extraction, biomedical summarization algorithms, and clinical 
decision support systems. Souza et al. (2019)[52] describe their preliminary work with promising results on exploring conditional 
random fields (CRF) algorithms to perform NER in clinical pt-br texts. They used different fragments of our corpus and different an-
notations granularities (STYs and SGRs) to train and evaluate their model. Considering the best results in the exact-match approach, 
they achieved a 0.84 F1 score for “Pharmacologic Substance” and 0.71 for “Abbreviation” STYs, which is in line with the IAA scores 
that we calculated. For the SGRs “Disorder” and “Procedure,” they achieved 0.76 and 0.70, respectively.  
5.5 Additional remarks and future work 
Despite the extensive qualitative and quantitative analysis of the results, and recognition of the reproducibility of our corpus, the study 
limitations and future work need to be discussed. Because they were created from scratch, the guidelines went through a slow process 
of evolution, which occurred together with the maturation of the annotators, after an extended period of annotation and analysis of 
new cases. To solve the inconsistencies generated by constant guidelines updates over the course of annotation, Campillos et al. 
(2018)[4] executed homogenization scripts to track and fix some of these irregularities. We opted to maintain the corpus as it was 
delivered by the adjudicators, but with the final guidelines and corpus in hands, one can run scripts to harmonize annotations. Follow-
ing discussions with the annotators, we realized that the annotation task in clinical pt-br texts do not present any additional challenges 
if we compare with English texts, and this is reinforced by the similar IAA scores with other studies. Furthermore, we concluded that 
the annotation tool was essential for them with regard to project time constraints. They claimed that annotation suggestions based on 
previously labeled terms and UMLS API saved them a considerable amount of time. However, analyzing the annotation errors togeth-
er, we verified that the annotation assistant helped to spread some inconsistencies throughout the corpus. This was because, at some 
point, the annotation assistant became a very trusted feature for the annotators, occasioning it to be used quickly and carelessly by 
users, without the annotators checking if the assistant's suggestion was really valid. Additionally, the web-based annotation tool 
helped us to ease the complex logistics (already discussed by [5]) of training, monitoring and coordinating several annotators at dif-
ferent locations and times. 
     Thus, some guideline changes that should be followed by all annotators were overwhelmed by suggestions based on annotations 
made before the update. Therefore, the use of this kind of feature is beneficial, but it should be used carefully. Nevertheless, the 
UMLS API suggestion feature prevented the annotators from searching for a concept on the UMLS Metathesaurus browser, which 
was one of the complaints made by Deleger et al. (2012) [37], who indicated that access to an online browser slowed down the anno-
tation process. Another issue common to their study and ours was that, occasionally, the UMLS STY assignment was confusing, as 
the concept “chronic back pain,” is defined as a “Sign or Symptom,” but “chronic low back pain” is defined as a “Disease or Syn-
drome” for example. Additional types for “Negation” and “Abbreviation” annotation gave our corpus an even greater coverage of 
clinical NLP tasks, as proved by the application of our corpus in a Negation and Scope detection algorithm. Moreover, as a secondary 
contribution, we were able to build Negation cues and Abbreviations dictionaries for further research, which will be available as the 
SemClinBr corpus. To replicate this annotation task and address the difficulties associated both with annotation time and guidelines 
refinement, one could reduce the number of STYs by grouping them into SGRs, as proposed by McCray et al. (2001)[33] and applied 
in other annotation efforts like Albright et al. (2013)[32]. 
     The recruitment and extensive use of medical students in annotation helped us to finish the annotation considerably faster than if 
we had depended exclusively on physicians and health professionals due to their availability. In some sense, this reinforces Xia and 
Yetisgen-Yildiz (2012) claim[14], in which medical training is not the only factor to consider for biomedical annotation tasks. Con-
cerning a complete usefulness assessment of our corpus, we intend to apply it in many other clinical NLP tasks. For sequence labeling 
tasks, in particular, we want to measure the correlation between algorithm accuracy and IAA for each semantic type. To cover tem-
poral reasoning tasks, we want to expand our annotation schema and create a subset of this corpus with temporal annotation. Further-
more, we need to determine the effect a corpus homogenization process on these NLP/ML algorithms performances. 
6. Conclusion 
We have reported the entire development process of SemClinBr, a semantically annotated corpus for pt-br clinical NLP tasks to pro-
vide a common development and evaluation resource for biomedical NLP researchers. To the best of our knowledge, this is the first 
clinical corpus available for pt-br. Similar annotation projects were surveyed to identify common steps and lessons learned so that 
mistakes could be avoided and our work could be improved. Furthermore, from this survey, we identified a set of aspects that we can-
not find together in other projects (i.e., multi-institutional texts, multiple document types, various medical specialties, high granularity 
annotation, and a high number of documents), which makes us believe that our annotation task is one of the most complex in clinical 
NLP literature, considering its generality. We described the data selection, the design of the annotation guidelines (and its refinement 
process), the annotation tool development, and the annotation workflow. The reliability and usefulness of the corpus were assessed by 
extensive quantitative and qualitative analysis, including agreement score calculation, error analysis, and application of our corpus in 
clinical NLP algorithms. Finally, we conclude that the SemClinBr, as well as the developed annotation tool, guidelines, and Nega-
tion/Abbreviation dictionaries, could serve as a background for further clinical NLP studies, especially for the Portuguese language.  
7. Resource availability 
The resources produced here (i.e., corpus, annotation guidelines and negation/abbreviation dictionaries) will be made available to the 
clinical NLP community, with a license agreement regarding scientific and non-commercial use only. 
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